Your browser doesn't support javascript.
loading
Common γ-chain blocking peptide reduces in vitro immune activation markers in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Massoud, Raya; Enose-Akahata, Yoshimi; Tagaya, Yutaka; Azimi, Nazli; Basheer, Asjad; Jacobson, Steven.
Affiliation
  • Massoud R; Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892;
  • Enose-Akahata Y; Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892;
  • Tagaya Y; Cell Biology Laboratory, Division of Basic Science and Vaccine Research, University of Maryland School of Medicine, Baltimore, MD 21201;
  • Azimi N; Bioniz, LLC, Irvine, CA 92618.
  • Basheer A; Bioniz, LLC, Irvine, CA 92618.
  • Jacobson S; Viral Immunology Section, Neuroimmunology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892; jacobsons@ninds.nih.gov.
Proc Natl Acad Sci U S A ; 112(35): 11030-5, 2015 Sep 01.
Article in En | MEDLINE | ID: mdl-26283355

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Biomarkers / Paraparesis, Tropical Spastic Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2015 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Biomarkers / Paraparesis, Tropical Spastic Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2015 Document type: Article